title: Adaptive Biomedical Innovation.
abstract: Adaptive Biomedical Innovation (ABI) is a multistakeholder approach to product and process innovation aimed at accelerating the delivery of clinical value to patients and society. ABI offers the opportunity to transcend the fragmentation and linearity of decision-making in our current model and create a common collaborative framework that optimizes the benefit and access of new medicines for patients as well as creating a more sustainable innovation ecosystem.
authors.affiliation: Collegeville, Pennsylvania, USA.
authors.forename: P K
authors.initials: PK
authors.lastname: Honig
authors.affiliation: Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
authors.forename: G
authors.initials: G
authors.lastname: Hirsch
mesh_terms: D020811:Biomedical Technology / Q000639:trends*; D003299:Cooperative Behavior; D003657:Decision Making; D004059:Diffusion of Innovation; D006297:Health Services Accessibility; D006801:Humans; D017146:Models, Organizational